Article Text

PDF

Micro-RNA 155 controls the pathogenesis of autoimmune arthritis
  1. Stephan Blüml1,
  2. Michael Bonelli1,
  3. Birgit Niederreiter1,
  4. Antonia Puchner1,
  5. Georg Mayr1,
  6. Silvia Hayer1,
  7. Marije I Koenders2,
  8. Wim B van den Berg2,
  9. Josef Smolen1,
  10. Kurt Redlich1
  1. 1Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria
  2. 2Department of Rheumatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

Abstract

Objective Micro RNAs (miRNAs) are a new class of regulatory elements. Altered expression of miRNAs has been demonstrated in inflamed joints of patients suffering from rheumatoid arthritis (RA). However, the exact role of miRNAs in the pathogenesis of this disease has not been defined so far.

Methods Collagen induced arthritis (CIA) and K/BxN serum transfer arthritis was induced in wt and miR155−/− mice. Severity of arthritis was determined clinically and histologically. Anticollagen antibodies and cytokines were measured by ELISA. The cellular composition of the draining lymph node after induction of CIA was measured by flow cytometry.

Results Here the authors show that miR155−/− mice are completely protected from CIA. miR155 deficiency prevents the generation of pathogenic autoreactive B and T cells since anticollagen antibodies and the generation of antigen specific T cells are strongly reduced in miR155−/− mice. Moreover, Th17 polarisation of miR155−/− T cells is impaired as interleukin 17 (IL-17) and IL-22 levels are significantly reduced. Using the K/BxN serum transfer arthritis model, which only depends on innate effector mechanisms, the authors demonstrate that miR155−/− mice, although developing similar severity of joint inflammation, show significantly reduced local bone destruction due to reduced generation of osteoclasts.

Conclusion Taken together, this study demonstrates that miR155 is essentially involved in adaptive and innate immune reactions leading to autoimmune arthritis, and therefore might provide a novel target to treat RA.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.